BioSpace News Archive

The Baltimore Longitudinal Study of Aging was launched in 1958 by the National Institutes of Health. The idea was to follow and study the lives of healthy, active people over their lifetimes, rather than after they were dead.

Merck today announced that Mavenclad® (cladribine 10 mg tablets) has been selected as a Rapid Uptake Product1 by the Accelerated Access Collaborative (AAC).

Proceeds provide OMEICOS with the financial runway to conduct the Phase II Study PROMISE-AF and continue expansion into ophthalmology through US subsidiary

Research-based prototype model of antibiotic drug information provides clinical decision support to promote antibiotic stewardship

MaaT Pharma announced today that the company will present a poster summarizing the complete results from its ODYSSEE Phase 1b/2a trial (NCT02928523).

Enrollment in Phase 2 Cohort of Follicular Lymphoma Patients with EZH2 Activating Mutations on Track to be Completed by Year End

Alkahest Inc. announced today that Tony Wyss-Coray Ph.D., Alkahest’s co-founder and board member was named to TIME Health’s list of individuals who were most influential in transforming healthcare in 2018.

Financial Outlook for Fiscal 2019 Reflects Core Revenue Growth Acceleration, Margin Expansion and Enhanced Profitability

PolarityTE, Inc. (Nasdaq: PTE), a commercial stage biotechnology company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences, announced today it will attend and present at the Canaccord Genuity Medical Technologies and Diagnostics Forum

Torque, an immuno-oncology company developing first-in-class Deep Primed™ T Cell Therapeutics to direct immune power deep within the tumor microenvironment, announced today the appointment of F. Stephen Hodi, MD to the company’s Scientific Advisory Board and the appointment of Alex Bruni as Chief Operating Officer and Chief Financial Officer.